《Nature,5月4日,Rapid reconstruction of SARS-CoV-2 using a synthetic genomics platform》

  • 来源专题:COVID-19科研动态监测
  • 编译者: zhangmin
  • 发布时间:2020-05-05
  • Rapid reconstruction of SARS-CoV-2 using a synthetic genomics platform

    Tran Thi Nhu Thao, Fabien Labroussaa, […]Volker Thiel

    Nature (2020)

    Abstract

    Reverse genetics has been an indispensable tool revolutionising insights into viral pathogenesis and vaccine development. Large RNA virus genomes, such as from Coronaviruses, are cumbersome to clone and manipulate in E. coli due to size and occasional instability1–3. Therefore, an alternative rapid and robust reverse genetics platform for RNA viruses would benefit the research community. Here we show the full functionality of a yeast-based synthetic genomics platform to genetically reconstruct diverse RNA viruses, including members of the Coronaviridae, Flaviviridae and Paramyxoviridae families. Viral subgenomic fragments were generated using viral isolates, cloned viral DNA, clinical samples, or synthetic DNA, and reassembled in one step in Saccharomyces cerevisiae using transformation associated recombination (TAR) cloning to maintain the genome as a yeast artificial chromosome (YAC).

  • 原文来源:https://www.nature.com/articles/s41586-020-2294-9
相关报告
  • 《Nature,5月4日,A human monoclonal antibody blocking SARS-CoV-2 infection》

    • 来源专题:COVID-19科研动态监测
    • 编译者:zhangmin
    • 发布时间:2020-05-05
    • A human monoclonal antibody blocking SARS-CoV-2 infection Chunyan Wang, Wentao Li, Dubravka Drabek, Nisreen M. A. Okba, Rien van Haperen, Albert D. M. E. Osterhaus, Frank J. M. van Kuppeveld, Bart L. Haagmans, Frank Grosveld & Berend-Jan Bosch Nature Communications volume 11, Article number: 2251 (2020) Abstract The emergence of the novel human coronavirus SARS-CoV-2 in Wuhan, China has caused a worldwide epidemic of respiratory disease (COVID-19). Vaccines and targeted therapeutics for treatment of this disease are currently lacking. Here we report a human monoclonal antibody that neutralizes SARS-CoV-2 (and SARS-CoV) in cell culture. This cross-neutralizing antibody targets a communal epitope on these viruses and may offer potential for prevention and treatment of COVID-19.
  • 《5月4日_瑞士科学家利用合成基因组学平台快速重建SARS-CoV-2》

    • 来源专题:COVID-19科研动态监测
    • 编译者:xuwenwhlib
    • 发布时间:2020-05-05
    • 信息名称:瑞士科学家利用合成基因组学平台快速重建SARS-CoV-2 1.时间:2020年5月4日 2.机构或团队:瑞士伯尔尼大学病毒学与免疫学研究所 3.事件概要: 瑞士伯尔尼大学病毒学与免疫学研究所在Nature发表论文“Rapid reconstruction of SARS-CoV-2 using a synthetic genomics platform”。反向遗传学是研究病毒的发病机制和疫苗的发展的有效工具。文章展示了一个基于酵母的合成基因组学平台可以对多种RNA病毒进行重新构建,包括冠状病毒科、黄病毒科和副粘病毒科成员。通过使用病毒分离株、克隆病毒DNA、临床样品或合成DNA片段构建病毒亚基因组片段,利用转化相关重组克隆在酿酒酵母中进行一步重组,以保持基因组为酵母人工染色体(YAC)。T7 RNA聚合酶已被用于产生感染性的RNA以替代活病毒。基于该平台,能够在收到合成的DNA片段后仅一周的时间内,对SARS-CoV-2进行人工改造和复活。文章描述的新技术可以快速响应新兴病毒,因为它可以对RNA病毒变体进行实时功能表征。 4.附件: 原文链接:https://www.nature.com/articles/s41586-020-2294-9